Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Upexi (UPXI) EBIT (2020 - 2025)

Historic EBIT for Upexi (UPXI) over the last 6 years, with Q4 2025 value amounting to -$175.4 million.

  • Upexi's EBIT fell 1624038.3% to -$175.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$116.3 million, marking a year-over-year decrease of 45876.11%. This contributed to the annual value of -$12.5 million for FY2025, which is 4435.27% up from last year.
  • As of Q4 2025, Upexi's EBIT stood at -$175.4 million, which was down 1624038.3% from $69.2 million recorded in Q3 2025.
  • In the past 5 years, Upexi's EBIT registered a high of $69.2 million during Q3 2025, and its lowest value of -$175.4 million during Q4 2025.
  • Over the past 5 years, Upexi's median EBIT value was -$1.9 million (recorded in 2022), while the average stood at -$7.9 million.
  • The largest annual percentage gain for Upexi's EBIT in the last 5 years was 527953.02% (2025), contrasted with its biggest fall of 1624038.3% (2025).
  • Quarter analysis of 5 years shows Upexi's EBIT stood at -$2.5 million in 2021, then skyrocketed by 32.95% to -$1.7 million in 2022, then plummeted by 52.95% to -$2.6 million in 2023, then soared by 58.74% to -$1.1 million in 2024, then tumbled by 16240.38% to -$175.4 million in 2025.
  • Its EBIT stands at -$175.4 million for Q4 2025, versus $69.2 million for Q3 2025 and -$6.5 million for Q2 2025.